GleamWall
中文EN

SHFH Scientist Home Future Health Ltd

Perfumes, Cosmetics & Other Toilet Preparations · OTC · SEC CIK 2032609 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY—
TTM net income YoY-265.8%
TTM EPS YoY-402.6%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin42.3%
Operating margin-60.2%
Net margin-60.2%
FCF margin—
EBITDA margin-58.0%

Returns

ROE-364.9%
ROA-51.8%
ROIC (approx.)—
Asset turnover0.86x

Leverage & solvency

Liabilities / assets112.9%
Debt / equity—
Current ratio0.53x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.78x
Accruals ratio-11.5%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312025Q1*2024-12-31
Income statement
Revenue$211,984$82,878$188,756$88,075$39,604$31,552$44,824—
Cost of revenue$90,964$55,194$129,688$55,486$23,534$18,013$25,135—
Gross profit$121,020$29,109$59,068$32,589$16,070$13,539$19,689—
SG&A expense$112,808$126,961$161,140$185,315$63,915$51,687$12,695—
Operating income$8,212-$97,852-$102,072-$152,726-$47,845-$38,148$6,994—
Pretax income$8,212-$97,852-$102,072-$152,726-$47,845-$38,148$6,994—
Income tax$0$0$0$0$0-$935$935—
Net income$8,212-$97,852-$102,072-$152,726-$47,845-$37,213$6,059-$15,155
EBITDA$11,929-$94,132-$98,342-$151,012-$47,845-$38,148$6,994—
EPS (diluted)0.000.000.00—0.000.000.00—
Weighted avg. shares (diluted)23.72M23.72M23.72M—23.66M23.50M23.48M—
Banking
Deposits$50,396——$48,417————
Balance sheet
Cash & equivalents$13,653$9,047$15,332$68,888$275,610$111,386$16,135$18,621
Inventory$129,162$33,898$31,376$34,006$1,991$3,329$3,460$2,627
Current assets$226,075$125,324$131,904$192,246$325,732$114,715$19,595$21,248
PP&E, net$61,440$65,194$68,928$73,175—$0—$0
Total assets$607,898$529,844$558,759$644,365$723,008$114,715$19,595$21,248
Current liabilities$424,121$340,299$252,124$214,458$123,388$63,182$19,568$27,268
Total liabilities$686,103$616,168$547,332$530,974$456,004$63,182$19,568$27,268
Shareholders' equity-$78,205-$86,324$11,427$113,391$267,004$51,533$27-$6,020
Shares outstanding23.72M23.72M23.72M23.72M23.72M23.54M23.48M23.48M
Cash flow statement
Operating cash flow-$44,577-$12,845-$71,811-$138,804-$99,348-$5,294-$4,832$8,681
Financing cash flow$49,229$6,595$18,510$7,697$265,484$100,613$2,346-$9,021
Depreciation & amortization$3,717$3,720$3,730$1,714$0$0$0—

Free plan shows the latest 8 periods; Pro shows all 9 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.